Completed
A Double-blind Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo
NCT03333538
- Conditions
- Filoviridae Infections, Healthy Volunteers, Hemorrhagic Fever, Ebola, +5 more
- Locations
-
- Research Institute of Influenza Saint Petersburg, Russia